89 related articles for article (PubMed ID: 38535101)
21. Evidence of Advanced Pulmonary Vascular Remodeling in Obstructive Hypertrophic Cardiomyopathy With Pulmonary Hypertension.
Maron BA; Kleiner DE; Arons E; Wertheim BM; Sharma NS; Haley KJ; Samokhin AO; Rowin EJ; Maron MS; Rosing DR; Maron BJ
Chest; 2023 Mar; 163(3):678-686. PubMed ID: 36243062
[TBL] [Abstract][Full Text] [Related]
22. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.
Humbert M; Kovacs G; Hoeper MM; Badagliacca R; Berger RMF; Brida M; Carlsen J; Coats AJS; Escribano-Subias P; Ferrari P; Ferreira DS; Ghofrani HA; Giannakoulas G; Kiely DG; Mayer E; Meszaros G; Nagavci B; Olsson KM; Pepke-Zaba J; Quint JK; Rådegran G; Simonneau G; Sitbon O; Tonia T; Toshner M; Vachiery JL; Vonk Noordegraaf A; Delcroix M; Rosenkranz S;
Eur Respir J; 2023 Jan; 61(1):. PubMed ID: 36028254
[No Abstract] [Full Text] [Related]
23. Prognostic Value of Exercise as Compared to Resting Pulmonary Hypertension in Patients with Normal or Mildly Elevated Pulmonary Arterial Pressure.
Douschan P; Avian A; Foris V; Sassmann T; Bachmaier G; Rosenstock P; Zeder K; Olschewski H; Kovacs G
Am J Respir Crit Care Med; 2022 Dec; 206(11):1418-1423. PubMed ID: 35925022
[No Abstract] [Full Text] [Related]
24. Three- Versus Two-Drug Therapy for Patients With Newly Diagnosed Pulmonary Arterial Hypertension.
Chin KM; Sitbon O; Doelberg M; Feldman J; Gibbs JSR; Grünig E; Hoeper MM; Martin N; Mathai SC; McLaughlin VV; Perchenet L; Poch D; Saggar R; Simonneau G; Galiè N
J Am Coll Cardiol; 2021 Oct; 78(14):1393-1403. PubMed ID: 34593120
[TBL] [Abstract][Full Text] [Related]
25. Idiopathic pulmonary arterial hypertension phenotypes determined by cluster analysis from the COMPERA registry.
Hoeper MM; Pausch C; Grünig E; Klose H; Staehler G; Huscher D; Pittrow D; Olsson KM; Vizza CD; Gall H; Benjamin N; Distler O; Opitz C; Gibbs JSR; Delcroix M; Ghofrani HA; Rosenkranz S; Ewert R; Kaemmerer H; Lange TJ; Kabitz HJ; Skowasch D; Skride A; Jureviciene E; Paleviciute E; Miliauskas S; Claussen M; Behr J; Milger K; Halank M; Wilkens H; Wirtz H; Pfeuffer-Jovic E; Harbaum L; Scholtz W; Dumitrescu D; Bruch L; Coghlan G; Neurohr C; Tsangaris I; Gorenflo M; Scelsi L; Vonk-Noordegraaf A; Ulrich S; Held M
J Heart Lung Transplant; 2020 Dec; 39(12):1435-1444. PubMed ID: 33082079
[TBL] [Abstract][Full Text] [Related]
26. Role of Pulmonary Artery Wedge Pressure Saturation During Right Heart Catheterization: A Prospective Study.
Viray MC; Bonno EL; Gabrielle ND; Maron BA; Atkins J; Amoroso NS; Fernandes VLC; Maran A; Nielsen CD; Powers ER; Steinberg DH; Todoran TM; Di Salvo TG; Jackson GR; Houston BA; Tedford RJ
Circ Heart Fail; 2020 Nov; 13(11):e007981. PubMed ID: 33016102
[No Abstract] [Full Text] [Related]
27. Exercise Pulmonary Resistances Predict Long-Term Survival in Systemic Sclerosis.
Zeder K; Avian A; Bachmaier G; Douschan P; Foris V; Sassmann T; Moazedi-Fuerst FC; Graninger WB; Hafner F; Brodmann M; Salmhofer W; Olschewski H; Kovacs G
Chest; 2021 Feb; 159(2):781-790. PubMed ID: 32931822
[TBL] [Abstract][Full Text] [Related]
28. Pulmonary vascular resistance and clinical outcomes in patients with pulmonary hypertension: a retrospective cohort study.
Maron BA; Brittain EL; Hess E; Waldo SW; Barón AE; Huang S; Goldstein RH; Assad T; Wertheim BM; Alba GA; Leopold JA; Olschewski H; Galiè N; Simonneau G; Kovacs G; Tedford RJ; Humbert M; Choudhary G
Lancet Respir Med; 2020 Sep; 8(9):873-884. PubMed ID: 32730752
[TBL] [Abstract][Full Text] [Related]
29. Pulmonary hypertension thresholds: time to lower further?
Provencher S; Boucherat O; Potus F; Bonnet S
Lancet Respir Med; 2020 Sep; 8(9):834-836. PubMed ID: 32730751
[No Abstract] [Full Text] [Related]
30. How low should we go? Potential benefits and ramifications of the pulmonary hypertension hemodynamic definitions proposed by the 6th World Symposium.
Brusca SB; Zou Y; Elinoff JM
Curr Opin Pulm Med; 2020 Sep; 26(5):384-390. PubMed ID: 32701671
[TBL] [Abstract][Full Text] [Related]
31. Pulmonary arterial hypertension with below threshold pulmonary vascular resistance.
Ratwatte S; Anderson J; Strange G; Corrigan C; Collins N; Celermajer DS; Dwyer N; Feenstra J; Keating D; Kotlyar E; Lavender M; Whitford H; Whyte K; Williams T; Wrobel JP; Keogh A; Lau EM;
Eur Respir J; 2020 Jul; 56(1):. PubMed ID: 32341105
[TBL] [Abstract][Full Text] [Related]
32. Exercise Pulmonary Hypertension Predicts Clinical Outcomes in Patients With Dyspnea on Effort.
Ho JE; Zern EK; Lau ES; Wooster L; Bailey CS; Cunningham T; Eisman AS; Hardin KM; Farrell R; Sbarbaro JA; Schoenike MW; Houstis NE; Baggish AL; Shah RV; Nayor M; Malhotra R; Lewis GD
J Am Coll Cardiol; 2020 Jan; 75(1):17-26. PubMed ID: 31918830
[TBL] [Abstract][Full Text] [Related]
33. Haemodynamic phenotypes and survival in patients with systemic sclerosis: the impact of the new definition of pulmonary arterial hypertension.
Xanthouli P; Jordan S; Milde N; Marra A; Blank N; Egenlauf B; Gorenflo M; Harutyunova S; Lorenz HM; Nagel C; Theobald V; Lichtblau M; Berlier C; Ulrich S; Grünig E; Benjamin N; Distler O
Ann Rheum Dis; 2020 Mar; 79(3):370-378. PubMed ID: 31818805
[TBL] [Abstract][Full Text] [Related]
34. Early treatment with ambrisentan of mildly elevated mean pulmonary arterial pressure associated with systemic sclerosis: a randomized, controlled, double-blind, parallel group study (EDITA study).
Pan Z; Marra AM; Benjamin N; Eichstaedt CA; Blank N; Bossone E; Cittadini A; Coghlan G; Denton CP; Distler O; Egenlauf B; Fischer C; Harutyunova S; Xanthouli P; Lorenz HM; Grünig E
Arthritis Res Ther; 2019 Oct; 21(1):217. PubMed ID: 31655622
[TBL] [Abstract][Full Text] [Related]
35. How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).
Pieske B; Tschöpe C; de Boer RA; Fraser AG; Anker SD; Donal E; Edelmann F; Fu M; Guazzi M; Lam CSP; Lancellotti P; Melenovsky V; Morris DA; Nagel E; Pieske-Kraigher E; Ponikowski P; Solomon SD; Vasan RS; Rutten FH; Voors AA; Ruschitzka F; Paulus WJ; Seferovic P; Filippatos G
Eur Heart J; 2019 Oct; 40(40):3297-3317. PubMed ID: 31504452
[TBL] [Abstract][Full Text] [Related]
36. A Concerning Trend for Patients With Pulmonary Hypertension in the Era of Evidence-Based Medicine.
Maron BA; Ryan JJ
Circulation; 2019 Apr; 139(16):1861-1864. PubMed ID: 30986105
[No Abstract] [Full Text] [Related]
37. An overview of the 6th World Symposium on Pulmonary Hypertension.
Galiè N; McLaughlin VV; Rubin LJ; Simonneau G
Eur Respir J; 2019 Jan; 53(1):. PubMed ID: 30552088
[TBL] [Abstract][Full Text] [Related]
38. Haemodynamic definitions and updated clinical classification of pulmonary hypertension.
Simonneau G; Montani D; Celermajer DS; Denton CP; Gatzoulis MA; Krowka M; Williams PG; Souza R
Eur Respir J; 2019 Jan; 53(1):. PubMed ID: 30545968
[TBL] [Abstract][Full Text] [Related]
39. Incidence of pulmonary hypertension and determining factors in patients with systemic sclerosis.
Coghlan JG; Wolf M; Distler O; Denton CP; Doelberg M; Harutyunova S; Marra AM; Benjamin N; Fischer C; Grünig E
Eur Respir J; 2018 Apr; 51(4):. PubMed ID: 29563168
[TBL] [Abstract][Full Text] [Related]
40. Increasing Incidence and Prevalence of World Health Organization Groups 1 to 4 Pulmonary Hypertension: A Population-Based Cohort Study in Ontario, Canada.
Wijeratne DT; Lajkosz K; Brogly SB; Lougheed MD; Jiang L; Housin A; Barber D; Johnson A; Doliszny KM; Archer SL
Circ Cardiovasc Qual Outcomes; 2018 Feb; 11(2):e003973. PubMed ID: 29444925
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
